Anti- Toxoplasma gondii Activities and Structure-Activity Relationships of Novel Fluoroquinolones Related to Trovafloxacin
- 1 July 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (7) , 1783-1787
- https://doi.org/10.1128/aac.43.7.1783
Abstract
Eleven novel fluoroquinolones closely related to trovafloxacin were evaluated for their in vitro activity against Toxoplasma gondii , and their structure-activity relationships were examined. The 50% inhibitory concentration (IC 50 ) of trovafloxacin against T. gondii was 2.93 μM; the IC 50 of the 11 analogs ranged from 0.53 to 14.09 μM. Six analogs had IC 50 s lower than that of trovafloxacin. Examination of the structure-activity relationships of the compounds revealed that addition of a -CH 3 at C-5 of the 1,8-naphthyridone ring, at C-2 of the azabicyclohexane ring, or on the -NH 2 at the 6 position of the azabicyclohexane ring resulted in a four- to sixfold increase in activity. Moreover, replacement of 2,4-difluorophenyl by cyclopropyl at N-1 of the 1,8-naphthyridone ring increased activity twofold, and moving the -NH 2 one atom further away from the azabicyclohexane ring decreased activity. There was no difference between the naphthyridone and quinolone analogs. These results indicate that structure-activity studies of compounds related to drugs active against T. gondii may be useful in producing compounds with more potent activities against the parasite.Keywords
This publication has 7 references indexed in Scilit:
- A plastid organelle as a drug target in apicomplexan parasitesNature, 1997
- DNA gyrase, topoisomerase IV, and the 4-quinolones.1997
- DNA gyrase, topoisomerase IV, and the 4-quinolonesMicrobiology and Molecular Biology Reviews, 1997
- Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosisAntimicrobial Agents and Chemotherapy, 1997
- DNA gyrase, topoisomerase IV, and the 4-quinolones.Microbiology and Molecular Biology Reviews, 1997
- Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteersJournal of Antimicrobial Chemotherapy, 1995
- Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1991